|
⚲
|
| Keyboard |
| Joe Cunningham | |
|---|---|
| Firm | |
| Address | 8333 Douglas Avenue Suite 1600 Dallas, TX 75225 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Gradalis Inc | 021-548754 | Director | 12.7 M of 30.0 M |
||
| Clairity Inc | 021-461907 | Director | 6.7 M of 30.0 M |
||
| Clairity Inc | 021-389048 | Director | 3.8 M of 9.0 M |
||
| Biostable Science & Engineering Inc | 021-362229 | Director | 4.2 M of 4.2 M |
||
| Remedy Applications Inc | 021-342832 | Director | 10.0 M of 10.0 M |
||
| Beta Cat Pharmaceuticals Inc | 021-315497 | Director | 2.6 M of 6.0 M |
||
| Millipede Inc | 021-305231 | Director | 43.2 M of 43.2 M |
||
| D5 Pharma Inc | 021-129598 | Director | 1.0 M of 2.5 M |
||
| Shvms LLC | |||||
| Sante Health Ventures V LP | 021-508800 | Director | 258.4 M of 300.0 M |
329.2 M | |
| SHV Opportunities A LLC | 021-533091 | Director | 15.4 M of 15.4 M |
25.3 M | |
| Sante Health Ventures IV LP | 021-394149 | Director | of 250.0 M |
307.1 M | |
| Sante Health Ventures IV Parallel A LP | 021-394149 | Director | of 250.0 M |
126.1 M | |
| Sante Health Ventures III LP | 021-306577 | Promoter | of 200.0 M |
281.1 M | |
| Sante Health Ventures I Annex Fund LP | 021-238924 | Promoter | of 15.0 M |
3.0 M | |
| Sante Health Ventures II LP | 021-156686 | Promoter | 139.0 M of 139.0 M |
68.5 M | |